Announcing a TAFIa mutant with a 180-fold increased half-life and concomitantly a strongly increased antifibrinolytic potential.
Ceresa
E
E
Peeters
M
M
Declerck
P J
PJ
Gils
A
A
D025901:Carboxypeptidase B2 / Q000737:chemistry / Q000235:genetics*; D005342:Fibrinolysis; D006207:Half-Life; D006487:Hemostasis; D006801:Humans; D009154:Mutation
D025901:Carboxypeptidase B2